REFERENCE
FDA.FDA Drug Safety Communication: New contraindication and updated warning on kidney impairment for Reclast (zoledronic acid). Internet Document: [2 pages], 30 Aug 2011. Available from: URL: http://www.fda.gov
Rights and permissions
About this article
Cite this article
New contraindication added to Reclast drug label. React. Wkly. 1368, 3 (2011). https://doi.org/10.2165/00128415-201113680-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201113680-00007